NiXEN entered into exclusive discussions to dispose of the shares in Vedici

Exclusive discussions to dispose of the shares in Vedici have began between the health group, 3i, NiXEN and CVC Capital Partners as a potential buyer.

The transaction would represent a key milestone in the growth strategy of Vedici, led since the formation of the group in 2000 by its founders Jérôme Nouzarède and Michel Bodkier. The founders and managers of the group would increase their shareholding alongside CVC.

The transaction takes place in the broader context of the on-going consolidation of the sector and remains conditioned upon customary approvals.

Contributors:

• 3i, NiXEN et Vedici Advisors: Lazard, BNP Paribas, Société Générale
• CVC Capital Partners Advisors: JP Morgan, Rothschild
• Founders and Managers Advisors: Callisto